Wockhardt’s another breakthrough antibiotic: once-a-day β-lactam
enhancer, WCK 6777 with unique out-patient treatment advantage granted
Fast Track designation by US FDA and successfully completes Phase I study
conducted by National Institutes of Health, US
| Subscribe To Our Free Newsletter |
